1. Home
  2. GLO vs OSUR Comparison

GLO vs OSUR Comparison

Compare GLO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clough Global Opportunities Fund

GLO

Clough Global Opportunities Fund

HOLD

Current Price

$5.78

Market Cap

242.9M

Sector

Finance

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.96

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLO
OSUR
Founded
N/A
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.9M
214.1M
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
GLO
OSUR
Price
$5.78
$2.96
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
94.5K
318.8K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$167,064,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.98
$2.08
52 Week High
$6.09
$3.76

Technical Indicators

Market Signals
Indicator
GLO
OSUR
Relative Strength Index (RSI) 51.78 41.98
Support Level $5.62 $2.87
Resistance Level $5.80 $2.96
Average True Range (ATR) 0.07 0.12
MACD 0.00 -0.03
Stochastic Oscillator 25.52 14.77

Price Performance

Historical Comparison
GLO
OSUR

About GLO Clough Global Opportunities Fund

Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: